476493-08-0

Basic information

• Product Name: 2-Piperazinemethanol,1-methyl-,(2S)-(9CI)
• Synonyms: 2-Piperazinemethanol,1-methyl-,(2S)-(9CI);(S)-(1-methylpiperazin-2-yl)methanol
• CAS NO: 476493-08-0
• Molecular Formula: C₆H₁₄N₂O
• Molecular Weight: 130.19
• Product Categories: AMINETERTIARY;PIPERAZINE
• Mol File: 476493-08-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Piperazinemethanol,1-methyl-,(2S)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Piperazinemethanol,1-methyl-,(2S)-(9CI)(476493-08-0)
• EPA Substance Registry System: 2-Piperazinemethanol,1-methyl-,(2S)-(9CI)(476493-08-0)

Safety Data

• Hazardous Substances Data: 476493-08-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Piperazinemethanol,1-methyl,(2S)-(9CI) is used as a building block for the development of new drugs and therapeutic agents due to its versatile structure and potential biological and pharmacological activities.
Used in Organic Synthesis:
2-Piperazinemethanol,1-methyl,(2S)-(9CI) is used as a key intermediate in the synthesis of various organic compounds, taking advantage of its unique structure and functional groups.

Upstream product

• 159532-59-9 (2S)-1-{[(1,1-dimethylethyl)oxy]carbonyl}-2-piperazinecarboxylic acid 

Relevant articles and documents

PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS

A compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (Syk) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory disease and/or allergic disorders, and in cancer therapy, specifically heme malignancies, and autoimmune conditions.

PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS

A compound of formula (I) or a salt thereof; which is an inhibitor of spleen tyrosine kinase (Syk) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory disease and/or allergic disorders, and in cancer therapy, specifically heme malignancies, and autoimmune conditions.

QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS

A quinazoline derivative of the formula (I): (A chemical formula should be inserted here - please see paper copy enclosed) Formula I wherein the substituents are as defined in the text for use in the production of an anti proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm blooded animal such as man.

CHEMICAL COMPOUNDS

Quinazoline derivatives of formula (I); for use in the treatment of proliferative diseases such as cancer and in the preparation of medicaments for use in the treatment of proliferative diseases, and to processes for their preparation, as well as pharmaceutical compositions containing them as active ingredient.